I especially appreciate Mr. Kennedy's questionings, especially around the biosimilar market.
Our overall goal, as you know, on both sides of the aisle is to see to it that the Congress produces effective legislati...
But Congress is going to move and we want to move together so that we end up keeping the promise to the American people ...
I think it is one of the reasons that we wanted you here today; so that the small bio people would have a voice in the h...
it is my hope that we might consider Federal legislation regarding transparency.
I think we are really very happy to have this session here today to try to untangle the drug supply chain.
Yes, let's use discounts because rebate--the connotation of a rebate, to me, is I associate that with consumers but I do...
I am proud of the bipartisan work, but it is critical that we recognize that the work cannot and will not stop there.
the rising drug costs and need for greater transparency in the whole chain.
To the manufacturers, again: Are there any other fees or monies that are associated with manufacturers and PBMs that I h...
I still don't quite get it but I want to move on to my next question.